London - (NewMediaWire) - March 06, 2019 - Argentum 47, Inc. (www.arg47.com) (OTC: ARGQ) and its fully-owned foreign subsidiaries, a specialist in both Retail and Corporate Financial Services and Corporate Consultancy, with offices located in Dubai and the United Kingdom, would like to announce that today, its wholly owned subsidiary, Cheshire Trafford (UK) Limited, entered into a long term contractual agreement with Global Alternative Administration S.L. (“GAA”) in order to allow the company to become an “Introducer Appointed Representative” of new business to our subsidiary in the United Kingdom.Over the years, Global Alternative Administration, a Spanish Limited Company, has generated significant amounts of new business but is not licensed to give any form of regulated Financial Advice. Our subsidiary, Cheshire Trafford, is fully licensed by the UK FCA to give such regulated Financial Advice.This newly formed business relationship will commence immediately and will result in expanding the capability of the Cheshire Trafford office in Yorkshire. This agreement with Global Alternative Administration contemplates an influx of circa 24,000,000 GBP (approximately US$31,600,000) of new Funds under Administration for our Company over the coming 12 months. The basic terms of the executed agreement are that Cheshire Trafford will earn a one-off fee of 1,200 GBP (approximately US$1,585) per client introduced and thereafter a split of the initial commission fees and also a split of the trail commission fees (1% per of the Funds under Administration) generated.Nick Tuke, Director of Cheshire Trafford (UK) Limited, said: “This is the second contractual agreement that we have entered into in order to expand the services of Cheshire Trafford but will certainly be the first to start to produce a torrent of new business. We are working with Global Alternative Administration, also known as ‘The Pension Admin Team’, this week to ensure we are all aware of the procedures, the processing and all of the operational duties in order to make this a successful business relationship. The new business flow will enhance the profitability of Cheshire Trafford significantly and, of course, its Funds under Administration. The relationship also provides a wonderful template for similar companies that we are currently talking to in a similar way.”Enzo Taddei, Director of Argentum 47, Inc., said: “When we acquired Cheshire Trafford back in August of 2018, we knew that we would have a lot of work ahead of us in order to set up new procedures and get the team thinking, acting and reacting in accordance to our business model. We were somewhat fixated on the idea of acquiring as many of Independent Financial Advisory firms as possible but then we realised that we had bought a Company with extremely valuable licenses and also a lot of potential for organic growth. By entering into these Appointed Representative (AR) and Introducer Appointed Representative (IAR) agreements like the one we announced in Q4 2018 regarding Aurum Wealth Management and this new one with Global Alternative Administration, we have found a way to grow Cheshire Trafford’s Funds under Administration exponentially at practically zero cost and without the need of the arduous financial statement audits that, as we all know, take forever to get done. With that said, we are still contemplating further acquisitions in the United Kingdom and also in South East Asia.”About Argentum 47, Inc. and Subsidiaries.Argentum 47, Inc. (“Argentum”) is a full service Financial Intermediary, Corporate Consultancy, Retail and Corporate Financial Services Company. Through its wholly-owned foreign subsidiaries, it advises both business and retail customers with their most critical decisions and opportunities pertaining to growth, capital needs, structure and the development of their financial plans. With offices in Dubai and the United Kingdom, Argentum has developed significant relationships in the U.S., U.K., Central Europe, the Middle East and South East Asia to assist clients in realizing their full ...
Tulsa, OK - (NewMediaWire) - March 06, 2019 - AppSwarm, Corp. (OTC: SWRM) announces it has executed an agreement with HerbSwift, an Endocannabinoid supplement company, to utilize the DeliverySwift last mile delivery technology.AppSwarm announced it had signed an agreement with HerbSwift to utilize DeliverySwift’s technology for their CBD and Endocannabinoid line of products.HerbSwift is a mobile app and E-commerce platform, powered by DeliverySwift that will marry together the disruptive LEGAL Endocannabinoid System Support & Wellness industry with the mobile On-Demand Economy. Users will be able to rate, review and purchase all of the most reputable brands of Endocannabinoid Support Supplements, enjoy friction-less checkout, live-track their orders, receive their order at their doorstep same day and even schedule future orders of their supplements for themselves, friends, relatives or their pets. www.herbswift.com The U.S. Hemp Authority™ Certification Program is our industry’s initiative to provide high standards, best practices, and self-regulation, giving confidence to consumers and law enforcement that hemp products are safe and legal. The U.S. Hemp Authority™ Certification Program is an effort funded by the US Hemp Roundtable and joined by organizations such as the Hemp Industries Association, industry-leading firms, top-tier testing laboratories, and quality assessors to develop comprehensive guidance for growers and processors of hemp. www.ushempauthority.orgHerbSwift, Inc. aims to distribute only those brands that are meeting the stringent self-regulatory standards of the U.S. Hemp Authority™ and passing a third-party audit. Once these standards are met, participants will be licensed to use the Certified Seal of the U.S. Hemp Authority™ on their products beginning in early 2019.Ron Brewer, the CEO of AppSwarm, commented, “We are very pleased to announce HerbSwift as our new partner in the cannabis distributor network. The deal with HerbSwift comes on the heels of our agreement with ‘I Heart Canna’, which is only the first of what we project will be many more cannabis distributors and dispensaries coming on to the network for the first half of 2019. DeliverySwift offers a ‘track and tracing’ technology solution for cannabis retailers and dispensaries to adhere to compliance, but also adds direct to consumer sales to their business model.”About DeliverySwiftDeliverySwift is an On-Demand logistics last mile delivery platform that acts as an intermediary between merchants and prospective buyers who wish to get products from local merchants delivered to their doorstep. DeliverySwift’s focus is direct to consumer deliveries for such products as groceries, furniture, pharmacies, Cannabis dispensaries and small bulk job site materials based on local driver transport capacities. www.deliveryswift.ioAbout APPSWARMAppSwarm is a technology company specializing in the accelerated development and publishing of mobile apps and other software platforms for gaming and business applications and seeks to acquire symmetric business opportunities. AppSwarm partners with and assists other development firms in technology development, business management, and funding needs.For more information, visit us at www.app-swarm.com, or follow us on www.facebook.com/AppSwarm or Twitter https://twitter.com/AppSwarm Request More InformationTo receive status updates on our company we invite you to register to our investor mailing list at http://www.app-swarm.com/investors/Forward-Looking Statements:"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking statements that are subject to risk and uncertainties including, but not limited to, the impact of competitive products, product demand, market acceptance risks, fluctuations in operating results, political risk and other risks detailed from time to time in the Company's filings with OTCMarkets.com and as required to the Securities and Exchange Commission. These risks could cause SWRM's actual results to differ ...
New York, NY - (NewMediaWire) - March 6, 2019 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has canceled its previously planned corporate action to amend its articles of incorporation to increase its authorized share capital (“authorized shares”). The Company’s authorized shares limit will remain at 100,000,000 for the foreseeable future. The Company decided to withdraw this planned corporate action due to more favorable recent market conditions as well as meaningful progress realized with respect to its ongoing business initiatives. In other news, the Company has completed both the front and back-end templates for its E-Commerce site (www.taurigum.com) and is currently implementing some final revisions and modifications. The Company expects to receive its initial tranche of Tauri-Gum™ inventory within the very near term and proceed with its commercial product launch, later this month (March 2019). ABOUT: TAURIGA SCIENCES, INC.Tauriga Sciences, Inc. (TAUG) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-GumTM. See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.In addition, the Company is currently constructing an E-Commerce site for the sale of its CBD Infused Chewing Gum. This site is being constructed under the following URL address: www.taurigum.com Forward-Looking StatementsThis press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking ...
Brookfield, WI - (NewMediaWire) - March 06, 2019 - Trident Brands Inc. (OTCQB: TDNT) today announced that their Brain Armor® brand of neuro-nutrition supplements (soft gels and concentrate) is now available with CVS Pharmacy, the retail division of CVS Health.Brain health is a rapidly growing segment supported by strengthening consumer awareness and values. Brain Armor® offers a range of clinically-proven supplements formulated to support the brain at every stage of life through targeted neuro-nutrition.“This nationwide listing with CVS reflects the significant investment Brain Armor® has made in both clinical research and product formulation. The confidence in the Brain Armor® brand has led to numerous partnerships with elite athletes, professional sports teams and organizations – such as the NFL Alumni,” said Anthony Pallante, Chairman & Chief Executive Officer, Trident Brands Inc. “Our entire team is very excited to extend Brain Armor® availability and advance our mission to improve brain health in partnership with CVS.”About Brain Armor® Brain Armor is on a mission to improve cognitive health, well-being and performance at every stage of life and on every field of play. Our products are clinically-proven dietary supplements formulated with omega-3, healthy fats and vital nutrients, designed to support structural brain health and performance. Brain Armor products are vegetarian, made in the USA and are a regular part of many professional and elite amateur athlete and team conditioning programs. Brain Armor Inc. is a subsidiary of Trident Brands Incorporated (OTCQB: TDNT -- tridentbrands.com).For more information on Brain Armor®, please visit www.brain-armor.com and www.thelivingbrainproject.com.About Trident Brands, Inc.Trident Brands Incorporated is a publicly-traded nutraceutical company (OTCQB: TDNT), structured to rapidly develop private label, control label, brand label and proprietary ingredient platforms in the dynamic active nutrition, dietary supplement and functional ingredient categories. For more information, please visit www.tridentbrands.com.About CVS PharmacyCVS Pharmacy, the retail division of CVS Health, is America's leading retail pharmacy with over 9,800 locations. It is the first national pharmacy to end the sale of tobacco and the first pharmacy in the nation to receive the Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry. CVS Pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com.General information about CVS Pharmacy is available at http://www.cvshealth.com.Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995 that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and the Company's future performance, operations, and products. Such statements involve known and unknown risks, uncertainties and other factors that could cause the Company's actual results to differ materially from the results expressed or implied by such statements. Such risks and uncertainties include, without limitation, market acceptance of the Company's forthcoming line of nutritional products; the Company's compliance with applicable Food and Drug Administration regulations; the Company's reliance on third-party contractors to mix and produce its products; the Company's ability to develop an effective marketing strategy; the Company's ability to control advertising and marketing costs; the Company's ability to develop and increase awareness of its forthcoming brands; the success ...
